Marshall Wace, LLP Quotient LTD Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$1.89 - $3.12 $299,060 - $493,686	-158,233 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.34 - $3.77 $370,265 - $596,538	158,233 New	158,233 $370,000
Q1 2021 May 17, 2021	SELL	$3.57 - $6.2 $346,539 - $601,834	-97,070 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.4 - $7.32 $251,996 - $419,231	-57,272 Reduced 37.11%	97,070 $505,000
Q3 2020 Nov 16, 2020	BUY	$4.38 - $8.35 $676,017 - $1.29 Million	154,342 New	154,342 $794,000
Q1 2020 May 15, 2020	SELL	$2.54 - $9.38 $159,438 - $588,791	-62,771 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.07 - $9.51 $387,386 - $521,081	54,793 Added 686.8%	62,771 $597,000
Q3 2019 Nov 14, 2019	BUY	$7.77 - $11.26 $61,989 - $89,832	7,978 New	7,978 $62,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.